Related Experiment Video
Updated: Jun 16, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
AQP1 and SLC4A10 as candidate genes for primary open-angle glaucoma
Wenjing Liu1, Yutao Liu, Xue-Jun Qin
1Center for Human Genetics, Duke University Eye Center, Duke University Medical Center, Durham, NC 27710, USA.
Common sequence variants in AQP1 and SLC4A10 genes are not associated with primary open-angle glaucoma (POAG) risk in the Caucasian population. This study examined candidate genes involved in cerebrospinal fluid (CSF) production and POAG.
Area of Science:
- Ophthalmology
- Genetics
- Neuroscience
Background:
- Primary open-angle glaucoma (POAG) pathogenesis may involve reduced cerebrospinal fluid (CSF) pressure.
- Aquaporin 1 (AQP1) and solute carrier family 4, sodium bicarbonate transporter, member 10 (SLC4A10) are key genes in CSF production.
Purpose of the Study:
- To investigate the association between variants in AQP1 and SLC4A10 genes and POAG in a Caucasian population.
- To explore the role of CSF production genes in POAG etiology.
Main Methods:
- Genotyping of 11 single nucleotide polymorphisms (SNPs) in AQP1 and SLC4A10.
- Comparison of genotype frequencies between 382 POAG patients and 363 control subjects.
- Logistic regression analysis adjusted for gender.
Main Results:
- No statistically significant differences in genotype frequencies were observed for any tested SNPs in AQP1 and SLC4A10 between POAG and control groups (p>0.05).
Conclusions:
- Common sequence variants in AQP1 and SLC4A10 are not associated with increased risk for POAG in the Caucasian population.
- This is the first study to examine the link between AQP1, SLC4A10, and POAG risk.
Related Concept Videos
Aquaporins
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Angle Closure Glaucoma: Treatment
Pharmacogenomics: Identification of New Drug Targets

